• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Comparison of antibody responses to HIV infection in Ugandan women infected with HIV subtypes A and D.乌干达感染HIV-1 A和D亚型的女性对HIV感染的抗体反应比较。
AIDS Res Hum Retroviruses. 2015 Apr;31(4):421-7. doi: 10.1089/AID.2014.0081. Epub 2014 Nov 19.
2
Impact of HIV subtype on performance of the limiting antigen-avidity enzyme immunoassay, the bio-rad avidity assay, and the BED capture immunoassay in Rakai, Uganda.乌干达拉凯地区HIV亚型对有限抗原亲和力酶免疫测定(即伯乐亲和力测定)及BED捕获免疫测定性能的影响
AIDS Res Hum Retroviruses. 2014 Apr;30(4):339-44. doi: 10.1089/aid.2013.0169. Epub 2013 Oct 25.
3
Immune responses in Ugandan women infected with subtypes A and D HIV using the BED capture immunoassay and an antibody avidity assay.乌干达感染 A 型和 D 型 HIV 的女性的免疫反应,使用 BED 捕获免疫测定法和抗体亲和力测定法。
J Acquir Immune Defic Syndr. 2014 Apr 1;65(4):390-6. doi: 10.1097/QAI.0000000000000006.
4
Validation of the Limiting Antigen Avidity Assay to Estimate Level and Trends in HIV Incidence in an A/D Epidemic in Rakai, Uganda.乌干达拉凯地区A/D型艾滋病流行中用于估计HIV发病率水平及趋势的有限抗原亲和力检测法的验证
AIDS Res Hum Retroviruses. 2019 Apr;35(4):364-367. doi: 10.1089/AID.2018.0207. Epub 2019 Jan 29.
5
Identification and validation of a multi-assay algorithm for cross-sectional HIV incidence estimation in populations with subtype C infection.鉴定和验证一种适用于 C 亚型感染人群的横断面 HIV 发病率估计的多检测算法。
J Int AIDS Soc. 2018 Feb;21(2). doi: 10.1002/jia2.25082.
6
Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations.用于估计B亚型人群横断面发病率的改良第四代人类免疫缺陷病毒酶免疫测定法的开发与评估
AIDS Res Hum Retroviruses. 2016 Aug;32(8):756-62. doi: 10.1089/AID.2015.0198. Epub 2016 May 5.
7
Short Communication: Heightened HIV Antibody Responses in Postpartum Women as Exemplified by Recent Infection Assays: Implications for Incidence Estimates.简短通讯:以近期感染检测为例,产后女性中HIV抗体反应增强:对发病率估计的影响
AIDS Res Hum Retroviruses. 2017 Sep;33(9):902-904. doi: 10.1089/AID.2016.0319. Epub 2017 May 24.
8
Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies.利用新的限性抗原亲和力测定法检测近期 HIV-1 感染:用于 HIV-1 发病率估计和亲和力成熟研究的潜力。
PLoS One. 2012;7(3):e33328. doi: 10.1371/journal.pone.0033328. Epub 2012 Mar 27.
9
Short Communication: Low False Recent Rate of Limiting-Antigen Avidity Assay Among Long-Term Infected Subjects from Guangxi, China.短讯:中国广西长期感染人群中限制抗原亲和力检测的低假近期率
AIDS Res Hum Retroviruses. 2015 Dec;31(12):1247-9. doi: 10.1089/aid.2015.0097. Epub 2015 Sep 2.
10
Impact of Early Antiretroviral Treatment Initiation on Performance of Cross-Sectional Incidence Assays.早期启动抗逆转录病毒治疗对横断面发病率检测结果的影响。
AIDS Res Hum Retroviruses. 2020 Jul;36(7):583-589. doi: 10.1089/AID.2019.0286. Epub 2020 May 27.

引用本文的文献

1
Evaluation of multi-assay algorithms for cross-sectional HIV incidence estimation in settings with universal antiretroviral treatment.在普遍开展抗逆转录病毒治疗的环境中,评估用于横断面 HIV 发病率估计的多分析算法。
BMC Infect Dis. 2022 Nov 11;22(1):838. doi: 10.1186/s12879-022-07850-0.
2
Use of HIV Recency Assays for HIV Incidence Estimation and Other Surveillance Use Cases: Systematic Review.使用 HIV 近期感染检测方法进行 HIV 发病率估计和其他监测应用案例:系统评价。
JMIR Public Health Surveill. 2022 Mar 11;8(3):e34410. doi: 10.2196/34410.
3
Impact of Early Antiretroviral Treatment Initiation on Performance of Cross-Sectional Incidence Assays.早期启动抗逆转录病毒治疗对横断面发病率检测结果的影响。
AIDS Res Hum Retroviruses. 2020 Jul;36(7):583-589. doi: 10.1089/AID.2019.0286. Epub 2020 May 27.
4
The concordance of the limiting antigen and the Bio-Rad avidity assays in persons from Estonia infected mainly with HIV-1 CRF06_cpx.在主要感染 HIV-1 CRF06_cpx 的爱沙尼亚感染者中,限定抗原与 Bio-Rad 亲和测定的一致性。
PLoS One. 2019 May 24;14(5):e0217048. doi: 10.1371/journal.pone.0217048. eCollection 2019.
5
Cross-sectional HIV incidence estimation in an evolving epidemic.横断面 HIV 发病率估计在不断演变的流行中。
Stat Med. 2019 Aug 30;38(19):3614-3627. doi: 10.1002/sim.8196. Epub 2019 May 21.
6
Comprehensive Profiling of HIV Antibody Evolution.全面剖析 HIV 抗体进化
Cell Rep. 2019 Apr 30;27(5):1422-1433.e4. doi: 10.1016/j.celrep.2019.03.097.
7
Validation of the Limiting Antigen Avidity Assay to Estimate Level and Trends in HIV Incidence in an A/D Epidemic in Rakai, Uganda.乌干达拉凯地区A/D型艾滋病流行中用于估计HIV发病率水平及趋势的有限抗原亲和力检测法的验证
AIDS Res Hum Retroviruses. 2019 Apr;35(4):364-367. doi: 10.1089/AID.2018.0207. Epub 2019 Jan 29.
8
Identification and validation of a multi-assay algorithm for cross-sectional HIV incidence estimation in populations with subtype C infection.鉴定和验证一种适用于 C 亚型感染人群的横断面 HIV 发病率估计的多检测算法。
J Int AIDS Soc. 2018 Feb;21(2). doi: 10.1002/jia2.25082.
9
Computational analysis of antibody dynamics identifies recent HIV-1 infection.计算分析抗体动力学可识别近期 HIV-1 感染。
JCI Insight. 2017 Dec 21;2(24):94355. doi: 10.1172/jci.insight.94355.
10
Short Communication: False Recent Ratio of the Limiting-Antigen Avidity Assay and Viral Load Testing Algorithm Among Cameroonians with Long-Term HIV Infection.简短通讯:喀麦隆长期感染艾滋病毒者中极限抗原亲和力检测与病毒载量检测算法的假近期比率
AIDS Res Hum Retroviruses. 2017 Nov;33(11):1114-1116. doi: 10.1089/AID.2017.0084. Epub 2017 Aug 7.

本文引用的文献

1
Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository.对CEPHIA储存库中的标本进行HIV发病率候选检测方法的独立评估。
AIDS. 2014 Oct 23;28(16):2439-49. doi: 10.1097/QAD.0000000000000429.
2
Immune responses in Ugandan women infected with subtypes A and D HIV using the BED capture immunoassay and an antibody avidity assay.乌干达感染 A 型和 D 型 HIV 的女性的免疫反应,使用 BED 捕获免疫测定法和抗体亲和力测定法。
J Acquir Immune Defic Syndr. 2014 Apr 1;65(4):390-6. doi: 10.1097/QAI.0000000000000006.
3
Development of methods for cross-sectional HIV incidence estimation in a large, community randomized trial.在一项大型社区随机试验中开发用于横断面 HIV 发病率估计的方法。
PLoS One. 2013 Nov 13;8(11):e78818. doi: 10.1371/journal.pone.0078818. eCollection 2013.
4
Short Communication: Defining optimality of a test for recent infection for HIV incidence surveillance.简短通讯:定义用于HIV发病率监测的近期感染检测的最优性
AIDS Res Hum Retroviruses. 2014 Jan;30(1):45-9. doi: 10.1089/aid.2013.0113. Epub 2013 Oct 26.
5
Impact of HIV subtype on performance of the limiting antigen-avidity enzyme immunoassay, the bio-rad avidity assay, and the BED capture immunoassay in Rakai, Uganda.乌干达拉凯地区HIV亚型对有限抗原亲和力酶免疫测定(即伯乐亲和力测定)及BED捕获免疫测定性能的影响
AIDS Res Hum Retroviruses. 2014 Apr;30(4):339-44. doi: 10.1089/aid.2013.0169. Epub 2013 Oct 25.
6
Evaluation of the false recent classification rates of multiassay algorithms in estimating HIV type 1 subtype C incidence.评估多种检测算法在估计HIV-1 C亚型发病率时的近期错误分类率。
AIDS Res Hum Retroviruses. 2014 Jan;30(1):29-36. doi: 10.1089/aid.2013.0055. Epub 2013 Sep 6.
7
Cross-sectional HIV incidence estimation in HIV prevention research.HIV 预防研究中的 HIV 发病率横断面估计。
J Acquir Immune Defic Syndr. 2013 Jul;63 Suppl 2(0 2):S233-9. doi: 10.1097/QAI.0b013e3182986fdf.
8
Differential specificity of HIV incidence assays in HIV subtypes A and D-infected individuals from Rakai, Uganda.乌干达拉克伊地区感染HIV-1 A亚型和D亚型个体中HIV发病率检测的差异特异性
AIDS Res Hum Retroviruses. 2013 Aug;29(8):1146-50. doi: 10.1089/aid.2012.0105. Epub 2013 May 29.
9
A new general biomarker-based incidence estimator.一种新的基于通用生物标志物的发病估计方法。
Epidemiology. 2012 Sep;23(5):721-8. doi: 10.1097/EDE.0b013e3182576c07.
10
Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies.利用新的限性抗原亲和力测定法检测近期 HIV-1 感染:用于 HIV-1 发病率估计和亲和力成熟研究的潜力。
PLoS One. 2012;7(3):e33328. doi: 10.1371/journal.pone.0033328. Epub 2012 Mar 27.

乌干达感染HIV-1 A和D亚型的女性对HIV感染的抗体反应比较。

Comparison of antibody responses to HIV infection in Ugandan women infected with HIV subtypes A and D.

作者信息

Longosz Andrew F, Morrison Charles S, Chen Pai-Lien, Brand Hilmarie H, Arts Eric, Nankya Immaculate, Salata Robert A, Quinn Thomas C, Eshleman Susan H, Laeyendecker Oliver

机构信息

1 Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases , NIH, Baltimore, Maryland.

出版信息

AIDS Res Hum Retroviruses. 2015 Apr;31(4):421-7. doi: 10.1089/AID.2014.0081. Epub 2014 Nov 19.

DOI:10.1089/AID.2014.0081
PMID:25317854
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4378664/
Abstract

We compared the serologic response to HIV infection in Ugandan women with HIV subtype A (N=82) and D (N=32) infection using a limiting antigen avidity assay (LAg-Avidity assay); 2,614 samples were analyzed. Study participants were followed a median of 6.6 years after HIV seroconversion. Samples were classified as assay positive if they had a LAg-Avidity assay result <1.5 normalized optical density units (OD-n). Women with subtype D infection were more likely to have delayed antibody maturation. During the first 2 years after seroconversion, the mean time that women had an assay-positive result (mean duration of recent infection, MDRI) was longer for women with subtype D infection than women with subtype A infection (267.9 days, 95% CI: 231.2-308.2 vs. 167.3 days, 95% CI: 151.8-185.9 days, p<0.01). The MDRI was also longer for women with subtype D infection after excluding low viral load samples and samples from women on antiretroviral therapy (ART). Women infected for >2 years were also more likely to be misclassified as recently infected in they had subtype D infection. Women with subtype D infection were also more likely to have antibody waning compared to women with subtype A infection. These findings may be related to the higher pathogenicity of subtype D HIV infection and are relevant to use of the LAg-Avidity assay for cross-sectional HIV incidence estimation in populations where subtype D infection is prevalent.

摘要

我们使用限量抗原亲和力测定法(LAg-亲和力测定法)比较了乌干达感染HIV-1 A亚型(N = 82)和D亚型(N = 32)的女性对HIV感染的血清学反应;共分析了2614份样本。研究参与者在HIV血清转化后中位随访6.6年。如果样本的LAg-亲和力测定结果<1.5标准化光密度单位(OD-n),则分类为检测阳性。感染D亚型的女性抗体成熟延迟的可能性更大。在血清转化后的头2年,感染D亚型的女性检测呈阳性结果的平均时间(近期感染的平均持续时间,MDRI)比感染A亚型的女性更长(267.9天,95%CI:231.2 - 308.2天 vs. 167.3天,95%CI:151.8 - 185.9天,p<0.01)。排除低病毒载量样本和接受抗逆转录病毒治疗(ART)女性的样本后,感染D亚型的女性的MDRI也更长。感染超过2年的感染D亚型的女性也更有可能被误分类为近期感染。与感染A亚型的女性相比,感染D亚型的女性抗体减弱的可能性也更大。这些发现可能与D亚型HIV感染的更高致病性有关,并且与在D亚型感染流行的人群中使用LAg-亲和力测定法进行横断面HIV发病率估计相关。